Hpv - OmicsDI

Show results for

Unknown (8636)
Genomics (900)
Transcriptomics (819)
Proteomics (82)
Methylation profiling (36)
Other (24)
Clinical (17)
Metabolomics (9)
Genomic (7)
Models (2)

Organisms

Homo sapiens (696)
Mus musculus (190)
Rattus norvegicus (22)
Arabidopsis thaliana (9)
Human papillomavirus (7)
Sus scrofa (7)
Danio rerio (6)
Saccharomyces cerevisiae (4)
Zea mays (3)
Bos taurus (3)
Caenorhabditis elegans (3)
Gambusia holbrooki (2)
Streptococcus pyogenes (2)
Staphylococcus aureus (2)
Pseudomonas aeruginosa PAO1 (2)
Canis lupus familiaris (2)
Escherichia coli (2)
Escherichia coli str. K-12 substr. MG1655 (2)
Drosophila melanogaster (2)
Nasonia giraulti (1)
Botrytis cinerea BcDW1 (1)
Staphylococcus sp. OJ82 (1)
Oryza rufipogon (1)
Thalassiosira pseudonana CCMP1335 (1)
Roseburia inulinivorans DSM 16841 (1)
Eucalyptus grandis (1)
Vibrio parahaemolyticus (1)
Cucumis melo (1)
Cervus nippon (1)
Chlorocebus aethiops (1)

Organisms

Homo sapiens (446)
Mus musculus (42)
human vaginal metagenome (12)
Human papillomavirus (9)
Human papillomavirus 16 (2)
unidentified (2)
Human papillomavirus sp. (1)
Homo sapiens environmental sample (1)
human reproductive system metagenome (1)
vaginal metagenome (1)
viral metagenome (1)
human metagenome (1)
Sus scrofa (1)
oral metagenome (1)
Clostridioides difficile (1)
human skin metagenome (1)
Macaca mulatta (1)
Bacteria (1)

Repository

ENA (794)
biostudies-arrayexpress (544)
geo (404)
pride (64)
EGA (36)
MassIVE (10)
dbGaP (7)
iProX (7)
MetaboLights (5)
MetabolomicsWorkbench (3)
BioModels (2)
ExpressionAtlas (1)
EVA (1)
GNPS (1)
GPMDB (1)
jPOST (1)
NODE (1)

Tissue

Cell culture (17)
Epithelial cell (10)
Keratinocyte (5)
Blood serum (4)
Tonsil (3)
Blood (2)
Ectocervical epithelium (2)
Endocervical epithelium (2)
Cervicovaginal fluid (2)
Tongue (2)
Head and neck squamous cell carcinoma cell (2)
Malignant cell (2)
Epithelial cell of cervix (2)
T cell (2)
Blood (2)
Keratinocytes (1)
Tongue (1)
Oropharyngeal squamous cell carcinoma cell (1)
Palate (1)
Head and neck cancer cell (1)
Anal canal (1)
Oropharynx (1)
Mouth (1)
Female reproductive system (1)
Peripheral blood mononuclear cell (1)
HEK-293T cell (1)
Endocervix (1)
Skin (1)
Bone marrow (1)
Macrophage (1)

Disease

Cervix carcinoma (10)
Cervical cancer (7)
Human papillomavirus infectious disease (4)
Colorectal Neoplasms (3)
Head and neck squamous cell carcinoma (3)
Anal Cancer (2)
Uterine Cervical Neoplasms (2)
Carcinoma (2)
HPV infection (2)
Cancer (2)
Oropharynx cancer (2)
Squamous cell carcinoma (2)
Human immunodeficiency virus infectious disease (2)
XCGD (1)
Integrated HPV16 only (1)
HPV positive (1)
Schizophrenia (1)
Portal hypertension (1)
Prostate carcinoma (1)
Normal (1)
Anus Neoplasms (1)
COVID-19 vaccine, colorectal cancer screening, cervical cancer screening, HPV vaccine (1)
Moderate cervical dysplasia (1)
Adenocarcinoma (1)
Colorectal Cancer (1)
Colonic Neoplasms (1)
Neoplasms (1)
Not Available (1)
Penile cancer (1)
Angelman syndrome (1)

Technology Type

Mass Spectrometry (67)
Shotgun proteomics (23)
Bottom-up proteomics (17)
Data-dependent acquisition (13)
Affinity purification coupled with mass spectrometry proteomics (8)
Mass spectrometry (4)
Data-independent acquisition (4)
Gel-based experiment (4)
ESI (3)
MSE (3)
SWATH MS (3)
DiaPASEF (2)
SRM/MRM (2)
Chemical cross-linking coupled with mass spectrometry proteomics (2)
NextSeq 500 (ILLUMINA), Illumina HiSeq 2500 (ILLUMINA) (1)
Illumina HiSeq 2500, ILLUMINA (1)
454 GS FLX Titanium, Illumina HiSeq 2000 (1)
Illumina HiSeq 2000 (1)
Mass spectrometry assay (1)
Proteogenomics (1)
Immunopeptidomics (1)
Top-down proteomics (1)

Instrument Platform

NextSeq 500 (9)
Illumina NovaSeq 6000 (6)
Illumina HiSeq 2500 (5)
Illumina HiSeq 2000 (3)
Illumina HiSeq 4000 (3)
Orbitrap Fusion Lumos (3)
Orbitrap Eclipse (2)
Q Exactive (2)
10X Genomics Chromium v3.1 with multiplexing kit (1)
DNBSEQ-G50 (1)
Illumina BeadArray Reader (part of Illumina BeadStation 500 (1)
ISCAN (1)
IScan Illumina (1)
The TLDA cards were analyzed on the Applied Biosystems 7900HT Real-Time PCR System. (1)
GenePix 4000A [Axon Instruments] (1)
Illumina HiSeq X (1)
Illumina MiSeq (1)
NextSeq 550 (1)
Instrument (1)
LTQ Orbitrap Velos (1)
LTQ Orbitrap XL (1)
Orbitrap Fusion (1)
LTQ Orbitrap (1)
Direct infusion MS - negative (1)
Liquid Chromatography MS - alternating - reverse phase (1)
Liquid Chromatography MS - negative - HILIC (1)
Liquid Chromatography MS - positive - HILIC (1)
Liquid Chromatography MS - positive - reverse-phase (1)
Liquid Chromatography MS - negative - reverse-phase (1)
Liquid Chromatography MS - negative - hilic (1)

Publication Date

2015 (118)
2014 (92)
2013 (85)
2025 (68)
2026 (66)
2011 (60)
2023 (59)
2016 (58)
2012 (57)
2024 (52)
2010 (52)
2022 (51)
2021 (45)
2018 (31)
2020 (28)
2008 (28)
2009 (26)
2007 (21)
2019 (17)
2017 (16)
2006 (4)
2005 (2)

UNIPROT ID/AC

A0A1S3MBI7 (1)
A0A1S3RDV7 (1)
A0A1S3SLA8 (1)
B5X3P0 (1)
A0A1S3N3T3 (1)
A0A1S3NZZ4 (1)
A0A1S3P094 (1)
A0A1S3PY93 (1)
Q19VI0 (1)
A0A1S3M1N8 (1)
A0A1S3NHN0 (1)
A0A1S3KZD6 (1)
A0A1S3SD21 (1)
A0A1S3LDQ3 (1)
A0A1S3P3J9 (1)
A0A1S3LD76 (1)
A0A1S3LEH9 (1)
A0A1S3MF70 (1)
A0A1S3MF67 (1)
A0A1S3MEX0 (1)
A0A1S3MEU5 (1)
A0A1S3RYH9 (1)
A0A1S3RYI5 (1)
A0A1S3P4C7 (1)
A0A1S3P297 (1)
A0A1S3P8N0 (1)
A0A1S3PB08 (1)
A0A1S3N1B9 (1)
C0HBN7 (1)
A0A1S3LIF1 (1)

CHEBI ID

CHEBI:43088 (2)
CHEBI:13097 (1)
CHEBI:21278 (1)
CHEBI:63163 (1)
CHEBI:6209 (1)
CHEBI:44590 (1)
CHEBI:21260 (1)
CHEBI:44513 (1)
CHEBI:6206 (1)
CHEBI:44708 (1)
CHEBI:44466 (1)
CHEBI:13094 (1)
CHEBI:47822 (1)
CHEBI:60107 (1)
CHEBI:21486 (1)
CHEBI:60111 (1)
CHEBI:47823 (1)
CHEBI:28538 (1)
CHEBI:47819 (1)
CHEBI:47821 (1)
CHEBI:21601 (1)
CHEBI:7203 (1)
CHEBI:77859 (1)
CHEBI:19473 (1)
CHEBI:11524 (1)
CHEBI:1021 (1)
CHEBI:12542 (1)
CHEBI:47984 (1)
CHEBI:1022 (1)
CHEBI:42925 (1)

Metabolite Name

Citicoline (2)
Cytidine monophosphate (2)
4-Hydroxyproline (2)
Argininosuccinic acid (2)
Gamma-L-Glutamyl-L-2-aminobutyrate (2)
Guanosine monophosphate (2)
IMP (2)
Creatinine (2)
Glutathione (2)
Guanosine (2)
Inosine (2)
Uridine (2)
N-methylnicotinate (1)
N(alpha)-gamma-L-glutamylhistamine (1)
O-carbamoyl-L-serine (1)
N(5)-hydroxy-L-ornithine (1)
1D-myo-inositol 2-acetamido-2-deoxy-alpha-D-glucopyranoside (1)
3-dehydrosphingosine (1)
(2-aminoethyl)phosphonic acid (1)
Adenosine 5'-(hexahydrogen pentaphosphate) (1)
S-adenosylmethioninamine (1)
(R)-carnitinamide (1)
Pyrimidine nucleoside (1)
N(1)-aminoaminopropylagmatine (1)
Carboxyspermidine (1)
S-inosyl-L-homocysteine (1)
2,4-diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose (1)
(2S,3R)-capreomycidine (1)
Pseudouridine 5'-phosphate (1)
Itaconyl-CoA (1)

First Public Date

2026 (103)
2025 (99)
2024 (87)
2023 (80)
2014 (73)
2022 (66)
2021 (60)
2020 (48)
2018 (47)
2019 (44)
2017 (35)
2015 (21)
2013 (18)
2016 (13)

Modelling Approach

Ordinary differential equation model (1)
Constraint-based model (1)

Study status

Completed (8)
Recruiting (4)
Active, not recruiting (2)
Withdrawn (1)
Not provided (1)
Not yet recruiting (1)

Lab affiliation

Department of Biology, University of Konstanz, Universitätsstraße 10, 78457 Konstanz, Germany (3)
Washington University in St. Louis (3)
Head of Laboratory Neuro-Oncology, Clinical and Cancer Proteomics, Neurology (2)
Institute of Technology, University of Tartu, Tartu, Estonia (2)
1 Department of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki and HUS Helsinki University Hospital, P.O.Box 263, FI-00029 HUS, Helsinki, Finland 2 Department of Biosciences and Nutrition, Karolinska Institutet, SE-171 76, Stockholm, Sweden. 3 Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland. (2)
Genecology Research Centre, University of the Sunshine Coast (2)
Åbo Akademi University, Faculty of Science and Engineering, Finland (2)
Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Heidelberg, Germany (1)
Proteome Research Molecular Medicine Heinrich Heine University Düsseldorf Düsseldorf Germany (1)
Center for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed to be University), University Road, Deralakatte, Mangalore 575018, India (1)
Shenzhen Hospital ,Southern Medical University (1)
Department of Obstetrics and Gynecology, Nagoya University, Aichi, Japan (1)
Laboratory of Experimental Pathology, GIGA-Cancer, University of Liege, Liege, Belgium (1)
Institute of Pathology, School of Medicine, Technical University of Munich, Munich, Germany Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany (1)
Affiliated Hospital of Qinghai University, Qinghai , China (1)
ProCan, Children’s Medical Research Institute, The University of Sydney, Westmead, NSW, Australia (1)
Molecular Therapy of Virus-Associated Cancers, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany (1)
Department of Biology University of Konstanz Germany (1)
Department of Biology University of Konstanz Germany (1)
Department of Biochemistry, Western University, Canada (1)
Molecular Therapy of Virus-Associated Cancers, German Cancer Research Center (DKFZ), Heidelberg, Germany. (1)
DKFZ F130 Division of Immunotherapy and Immunoprevention (1)
1Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, USA 2Institute for Quantitative and Computational Biosciences, University of California, Los Angeles, Los Angeles, CA, USA 3Molecular Biology Institute, University of California, Los Angeles, Los Angeles, CA, USA (1)
Associate Professor and Head-Proteomics Research, School of Biotechnology, Amrita Vishwa Vidyapeetham, Amritapuri Campus, Clappana PO., Kollam-690525, Kerala, India, Phone- 0476 2803119, 2803110 (lab head) (1)
Clinical Proteomics Mass Spectrometry, Department of Oncology-Pathology, Science for Life Laboratory and Karolinska Institutet, Stockholm, Sweden (1)
Associate Professor, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Blå Stråket 2, SE-41345, Göteborg, Sweden. (1)
Felix Hoppe-Seyler, Molecular Therapy of Virus-Associated Cancers, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany (1)
Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, P.R. China (1)
WTSI (1)
Institut de Génétique et de Biologie Moléculaire et Cellulaire, 67404 Illkirch CEDEX, France (1)

Keyword

Immunotherapy (2)
HPV positive (1)
Reproductive Cancers (1)
Renal Cell (1)
HPV cancer (1)
Physician Reimbursement (1)
Oropharyngeal (1)
Acute Lymphoblastic Leukemia (1)
Chronic Renal Disease (1)
Solid Organ Transplant (1)
Bintrafusp Alfa M7824 (1)
NHS-IL12 M9241 (1)
PD-1(L1) (1)
Aldesleukin (1)
Tremelimumab (1)
Inflammatory Bowel Disease (1)
MSS-CRC (1)
Environmental barriers to cancer screening (1)
Person-level barriers to cancer screening (1)
Metastatic tumor (1)
Phase Ib/II trial (1)
Neuroendocrine gastroenteropancreatic tumors (1)
Tertiary lymphoid structures (1)
Triple negative brest cancer (1)
HPV-associated cancer (1)
Malignant pleural mesothelioma (1)
Non clear-cell renal carcinoma (1)
TMB-high solid tumors (1)
MSI-high solid tumors (1)
Risk Factors (1)

IsPrivate

False (2)

Classification

viruses (12)
bacteria (1)

Modification

N6 (1)
2x(15)N labeled L-lysine (1)

Study type

Transcription profiling by array (306)
RNA-seq of coding RNA (116)
Methylation profiling by array (25)
Interventional (15)
Unknown experiment type (14)
Comparative genomic hybridization by array (13)
RNA-seq of non coding RNA (11)
Genotyping by array (9)
Transcription profiling by RT-PCR (5)
MicroRNA profiling by array (5)
DNA-seq (5)
RNA-seq of coding RNA from single cells (5)
Transcription profiling by SAGE (4)
Other (4)
ChIP-seq (3)
RNA-seq of total RNA (3)
ChIP-chip by tiling array (2)
ChIP-chip by array (2)
MicroRNA profiling by high throughput sequencing (2)
Methylation profiling by high throughput sequencing (2)
Animal - One-color microarray (1)
Human - Methylation microarray (1)
Human - One-color microarray (1)
Cell line - High-throughput sequencing (1)
RIP-seq (1)
Observational patient registry (1)
Observational (1)

Release Date

2025 (1063)
2022 (995)
2023 (894)
2021 (866)
2024 (752)
2020 (711)
2019 (581)
2018 (551)
2016 (430)
2017 (401)
2015 (401)
2014 (370)
2013 (249)
2012 (179)
2011 (177)
2026 (140)
2010 (120)
2009 (80)
2008 (68)
2007 (50)
2006 (28)
2005 (20)
2003 (16)
2004 (11)
2000 (10)
1999 (6)
2002 (4)
2001 (4)
1998 (3)

Location

United States (6)
Australia (4)
United Kingdom (2)
France (2)
Canada (1)
China (1)
Germany (1)
South Korea (1)
Japan (1)

Previous page
1 / 1054
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 1054
Next page

Sort by:

Relevance

Page size

Methylome Analysis of FF HPV+ and HPV- HNSCC samples

The analysis of the 6 methylomes by MeDIP-Seq comprise 3 HPV+ HNSCC samples and 3 HPV- HNSCC samples Analysis of the 6 methylomes, comprising 3 HPV+ HNSCC samples and 3 HPV- HNSCC samples

ORGANISM(S): Homo sapiens

2012-11-01 | E-GEOD-38263 | biostudies-arrayexpress

MicroRNA sequencing and Novel HPV miRNA discovery in HPV cell lines and human tissue samples

Human papillomaviruses (HPV) preferentially infect keratinocytes of mucous membranes or skin and cause numerous benign and malignant lesions at different anatomical locations. A number of DNA viruses encode their own miRNAs as well. To date, no studies have been able to validate viral miRNAs in papi...

ORGANISM(S): Homo sapiens

2013-08-18 | E-GEOD-42380 | biostudies-arrayexpress

Metabolic analysis of primary HPV18-genome containing human foreskin keratinocytes compared to untransfected donor-matched controls.

Not available

ORGANISM(S): Homo sapiens

ST002448 | MetabolomicsWorkbench

Subtypes of HPV-positive head and neck cancers are associated with HPV characteristics, copy number variations, PIK3CA mutation, and pathway signatures. [RNA-Seq]

Purpose: There is substantial heterogeneity within the human papillomavirus (HPV) positive head and neck cancer (HNC) tumors that predispose them to different outcomes, however this subgroup is poorly characterized due to various historical reasons. Experimental Design: we perform unsupervised gene...

ORGANISM(S): Homo sapiens

2016-05-13 | E-GEOD-74927 | biostudies-arrayexpress

HPV

PRJEB39426 | ENA

Epigenome analysis in HPV(-) and HPV(+) squamous cell carcinoma cell lines

Human papillomavirus (HPV)-associated head and neck cancers (HNSCCs) have a distinct risk profile and appreciate a prognostic advantage compared to HPV-negative HNSCC. Promoter hypermethylation has been widely recognized as an important mechanism in the progression of HNSCC, but the extent to which ...

ORGANISM(S): Homo sapiens

2010-12-01 | E-GEOD-24087 | biostudies-arrayexpress

Immortalization capacity of HPV types is inversely related to chromosomal instability in immortal descendants.

Human papillomavirus (HPV) induced immortalization of human foreskin keratinocytes (HFK) is a two-step process, including 1) the bypass of replicative senescence and acquisition of an extended lifespan, and 2) the outgrowth of immortal cells. Our previous study showed that the immortalization capaci...

ORGANISM(S): Homo sapiens

2016-08-01 | E-GEOD-72063 | biostudies-arrayexpress

Using MCIp, we enriched highly methylated DNA from a normal mucosa control and from three OPSCC patient subgroups regarding the HPV status: group A, DNA-RNA- (Tu1-Tu5); group B, DNA+RNA- (Tu6-Tu10); group C, DNA+RNA+ (Tu11-Tu15). 3 groups of tumor biopsies, 5 samples each regarding HPV status: DNA-R...

ORGANISM(S): Homo sapiens

2013-09-16 | E-GEOD-41152 | biostudies-arrayexpress

Gene expression analysis of TIL rich HPV driven head and neck tumours reveals a distinct B-cell signature when compared to HPV independent tumours.

Purpose: Human papilloma virus (HPV) associated head and neck squamous cell carcinoma (HNSCC) has a better prognosis than HPV(-) negative cancer. This may be due, in part, to the higher number of tumour infiltrating lymphocytes (TIL) in HPV(+) tumours. We used RNAseq to evaluate whether these differ...

ORGANISM(S): Homo sapiens

2016-09-01 | E-GEOD-72536 | biostudies-arrayexpress

Comparative proteomic analysis of HPV(+) oropharyngeal squamous cell carcinoma recurrence

The global rise of HPV(+) oropharyngeal squamous cell carcinoma (OPSCC) has generated considerable interest underlying its etiology and management. Despite an overall decline in head and neck malignancies, the incidence in OPSCC has by contrast sharply risen, with HPV(+) subtypes now comprising 80% ...

ORGANISM(S): Homo sapiens (Human)

2022-05-05 | PXD028618 | Pride

Previous page
1 / 1054
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 1054
Next page

Sort by:

Relevance

Page size

10535 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

UNIPROT ID/AC

CHEBI ID

Metabolite Name

First Public Date

Modelling Approach

Study status

Lab affiliation

Tags

Keyword

IsPrivate

Classification

Modification

Study type

Release Date

Location

OmicsDI is part of the ELIXIR infrastructure

Tweets